Targeting c-MET/HGF Signaling Pathway in Upper Gastrointestinal Cancers: Rationale and Progress

Publisher： Bentham Science Publishers

E-ISSN： 1873-5592|15|14|1302-1311

ISSN： 1389-4501

Source： Current Drug Targets, Vol.15, Iss.14, 2014-12, pp. : 1302-1311

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

MET As a Potential Target for the Treatment of Upper Gastrointestinal Cancers: Characterization of Novel c-Met Inhibitors from Bench to Bedside

By  

Current Medicinal Chemistry, Vol. 21, Iss. 8, 2014-01 ,pp. : 975-989

Bentham Science Publishers

Access to resources Recommend Favorite

The role of HGF/c-Met signaling in prostate cancer progression and c-Met inhibitors in clinical trials

By Varkaris Andreas   Corn Paul G   Gaur Sanchaika   Dayyani Farshid   Logothetis Christopher J   Gallick Gary E  

Expert Opinion on Investigational Drugs, Vol. 20, Iss. 12, 2011-12 ,pp. : 1677-1684

Informa Healthcare

Access to resources Recommend Favorite

Efficacy of Therapy with c-Met/HGF Inhibitors in Solid Tumors: A Systematic Review Based on 24 Clinical Trials

By  

Clinical Cancer Drugs, Vol. 3, Iss. 2, 2016-10 ,pp. : 87-99

Bentham Science Publishers

Access to resources Recommend Favorite

Efficacy of Therapy with c-Met/HGF Inhibitors in Solid Tumors: A Systematic Review Based on 24 Clinical Trials

By  

Clinical Cancer Drugs, Vol. 3, Iss. 2, 2016-10 ,pp. : 87-99

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting the Wnt/ββ-catenin signaling pathway in human cancers

By Yao Hisayuki   Ashihara Eishi   Maekawa Taira  

Expert Opinion on Therapeutic Targets, Vol. 15, Iss. 7, 2011-07 ,pp. : 873-887

Informa Healthcare

Access to resources Recommend Favorite